Literature DB >> 22294870

Home intravenous therapy: Accessibility for Canadian children and youth.

Dl Moore, R Bortolussi.   

Abstract

The administration of intravenous (IV) therapy at home is an alternative to hospitalization for treatment of infection and a number of other conditions, and has been demonstrated to be effective and safe, to reduce cost and to improve quality of life. While home IV therapy has many advantages for children, it is not uniformly available and access may be limited by age, geographical location and ability to pay. Physicians caring for children need to be aware of the indications for home IV therapy, its requirements and limitations, as well as whether this option is available for children in their care. Where access is limited, physicians should advocate for home IV therapy for children when it is medically indicated.

Entities:  

Keywords:  Antibiotic; Home intravenous therapy; Paediatric; Parenteral nutrition

Year:  2011        PMID: 22294870      PMCID: PMC3043043          DOI: 10.1093/pch/16.2.105

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  28 in total

Review 1.  Vascular access for home intravenous therapy in children.

Authors:  Walter J Chwals
Journal:  JPEN J Parenter Enteral Nutr       Date:  2006 Jan-Feb       Impact factor: 4.016

2.  Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis.

Authors:  Dena Nazer; Ibrahim Abdulhamid; Ronald Thomas; Sara Pendleton
Journal:  Pediatr Pulmonol       Date:  2006-08

3.  Outpatient intravenous medications in the management of cystic fibrosis.

Authors:  R W Rucker; G M Harrison
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

4.  Complications of outpatient parenteral antibiotic therapy in childhood.

Authors:  M Gomez; N Maraqa; A Alvarez; M Rathore
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

5.  Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients.

Authors:  E Shemesh; I Yaniv; M Drucker; S Hadad; Y Goshen; J Stein; S Ash; S Fisher; R Zaizov
Journal:  Med Pediatr Oncol       Date:  1998-02

6.  Children receiving chemotherapy at home: perceptions of children and parents.

Authors:  Bonnie Stevens; Patricia McKeever; Madelyn P Law; Marilyn Booth; Mark Greenberg; Stacey Daub; Amiram Gafni; Janet Gammon; Janet Yamada; Iris Epstein
Journal:  J Pediatr Oncol Nurs       Date:  2006 Sep-Oct       Impact factor: 1.636

7.  Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients.

Authors:  Virginie Colomb; Myriam Dabbas-Tyan; Pierre Taupin; Cécile Talbotec; Y Révillon; D Jan; Sophie De Potter; Anne-Marie Gorski-Colin; Michèle Lamor; Karen Herreman; Odile Corriol; Paul Landais; Claude Ricour; Olivier Goulet
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-03       Impact factor: 2.839

8.  Central venous catheter-related infections in children on long-term home parenteral nutrition: incidence and risk factors.

Authors:  V Colomb; M Fabeiro; M Dabbas; O Goulet; J Merckx; C Ricour
Journal:  Clin Nutr       Date:  2000-10       Impact factor: 7.324

9.  Surveillance of intravenous catheter-related infections among home care clients.

Authors:  M C White; K E Ragland
Journal:  Am J Infect Control       Date:  1994-08       Impact factor: 2.918

10.  Complications of home parenteral nutrition in a large pediatric series.

Authors:  D Knafelz; M Gambarara; A Diamanti; B Papadatou; F Ferretti; I Tarissi De Iacobis; M Castro
Journal:  Transplant Proc       Date:  2003-12       Impact factor: 1.066

View more
  2 in total

1.  Domiciliary administration of intravenous albumin in congenital nephrotic syndrome.

Authors:  Ben Christopher Reynolds; Charles William Pickles; Heather Joan Lambert; Milos Ognjanovic; Jean Crosier; Sally Ann Johnson; Yincent Tse
Journal:  Pediatr Nephrol       Date:  2015-08-07       Impact factor: 3.714

2.  Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era.

Authors:  G Anderson; G Deceuninck; Z Zhou; F D Boucher; Y Bonnier Viger; R Gilca; P De Wals
Journal:  Epidemiol Infect       Date:  2017-08-14       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.